Related Experiment Videos

Management of metabolic syndrome: aspirin

T Matthew Shields1, Charles H Hennekens

  • 1Universidad Central del Caribe, Bayamón, Puerto Rico.

Endocrinology and Metabolism Clinics of North America
|July 21, 2004
PubMed

Insights

Aspirin is crucial for treating and preventing cardiovascular disease (CVD), including heart attack and stroke. It is especially important as add-on therapy for individuals with metabolic syndrome, a common condition.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Metabolic Disorders

Background:

  • Cardiovascular disease (CVD) is the primary cause of death globally.
  • Metabolic syndrome affects a significant portion of the US population, including those with existing vascular disease and those at high risk.
  • Patients with metabolic syndrome face substantial risks for future cardiovascular events.

Purpose of the Study:

  • To review the evidence for aspirin in CVD treatment and prevention.
  • To highlight aspirin's role in managing patients with metabolic syndrome.

Main Methods:

  • Comprehensive review of existing scientific literature on aspirin and CVD.
  • Analysis of clinical trial data and observational studies.
  • Focus on evidence relevant to metabolic syndrome patients.

Main Results:

  • Aspirin demonstrates efficacy in both treating and preventing various forms of CVD.
  • The evidence supports aspirin's use across different patient groups, including those with prior events and high-risk individuals.
  • Aspirin is particularly beneficial as adjunctive therapy for metabolic syndrome.

Conclusions:

  • Aspirin is a cornerstone therapy for cardiovascular disease management.
  • Its role in preventing primary and secondary CVD events is well-established.
  • Aspirin's importance is amplified in patients with metabolic syndrome due to their elevated risk profile.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...